A study of extracellular vesicle concentration in active diabetic Charcot neuroarthropathy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2017-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejps.2016.09.009PMID 27637291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteoblast-derived microvesicles: A novel mechanism for communication between osteoblasts and osteoclasts.

  2015cited by this paper
• Charcot foot syndrome

  2015cited by this paper
• Inflammatory and bone turnover markers in a cross‐sectional and prospective study of acute Charcot osteoarthropathy

  2015cited by this paper
• High-Resolution Visualization of the Osteocyte Lacuno-Canalicular Network Juxtaposed to the Surface of Nanotextured Titanium Implants in Human.

  2015cited by this paper
• Membrane Microvesiculation and its Suppression

  2015cited by this paper
• Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles

  2015cited by this paper
• Biological properties of extracellular vesicles and their physiological functions

  2015cited by this paper
• Extracellular vesicle-mediated export of fungal RNA

  2015cited by this paper
• Emerging role of extracellular vesicles in inflammatory diseases

  2014cited by this paper
• Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy

  2014cited by this paper
• Extracellular vesicle-mediated transfer of membranous components from the highly malignant T24 urinary carcinoma cell line to the non-malignant RT4 urinary papilloma cell line

  2013cited by this paper
• Advanced Glycation End-Products

  2013cited by this paper
• The role of extracellular vesicles in phenotypic cancer transformation

  2013cited by this paper
• RAGE receptor and its soluble isoforms in diabetes mellitus complications

  2013cited by this paper
• Novel Use of a Dektak 150 Surface Profiler Unmasks Differences in Resorption Pit Profiles Between Control and Charcot Patient Osteoclasts

  2013cited by this paper
• Role of advanced glycation end products in cardiovascular disease.

  2012cited by this paper
• Plantar Temperature Response to Walking in Diabetes with and without Acute Charcot: The Charcot Activity Response Test

  2012cited by this paper
• Advances in Planar Lipid Bilayers and Liposomes

  2012influential reference
• Charcot Arthropathy in the Diabetic Foot

  2012cited by this paper
• The Charcot Foot in Diabetes

  2011cited by this paper
• Loss of RAGE Defense: A Cause of Charcot Neuroarthropathy?

  2011cited by this paper
• Post - prandial rise of microvesicles in peripheral blood of healthy human donors

  2011cited by this paper
• Evidence for osteocyte regulation of bone homeostasis through RANKL expression

  2011influential reference
• Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process

  2011cited by this paper
• The Charcot foot in diabetes.

  2011cited by this paper
• Exosomes/microvesicles as a mechanism of cell-to-cell communication.

  2010cited by this paper
• Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.

  2009cited by this paper
• Blood and Synovial Microparticles as Revealed by Atomic Force and Scanning Electron Microscope

  2009cited by this paper
• Proinflammatory Modulation of the Surface and Cytokine Phenotype of Monocytes in Patients With Acute Charcot Foot

  2009cited by this paper
• Mechanisms for the formation of membranous nanostructures in cell-to-cell communication

  2009cited by this paper
• Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand

  2008influential reference
• Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases.

  2008cited by this paper
• Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

  2007cited by this paper
• Biology of RANK, RANKL, and osteoprotegerin

  2007cited by this paper
• Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

  2006cited by this paper
• Advanced Glycation End‐Products Attenuate Human Mesenchymal Stem Cells and Prevent Cognate Differentiation Into Adipose Tissue, Cartilage, and Bone

  2005cited by this paper
• Nanotubular Highways for Intercellular Organelle Transport

  2004cited by this paper
• Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting?

  2004cited by this paper
• Applied Statistics and Probability for Engineers

  2004cited by this paper
• Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

  2003cited by this paper
• Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus

  2002cited by this paper
• Charcot Arthropathy of the Diabetic Foot. Current Concepts and Review of 36 Cases

  2002cited by this paper
• Regulatory mechanisms of osteoblast and osteoclast differentiation.

  2002cited by this paper
• The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

  2001cited by this paper
• Significance of chemokines and activated platelets in patients with diabetes

  2000cited by this paper
• Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques

  2000influential reference
• Configurations of fluid membranes and vesicles

  1997cited by this paper
• Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry.

  1997cited by this paper
• A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

  1993cited by this paper

• Exploring the role of exosomes in diabetic neuropathy: From molecular mechanisms to therapeutic potential.

  2025cites this paper
• Understanding exosomes: Part 2-Emerging leaders in regenerative medicine.

  2024cites this paper
• Adipose-Derived Stem Cell Exosomes Facilitate Diabetic Wound Healing: Mechanisms and Potential Applications

  2024cites this paper
• Diretrizes da Sociedade Brasileira de Angiologia e de Cirurgia Vascular sobre o pé diabético 2023

  2024cites this paper
• Brazilian Society of Angiology and Vascular Surgery 2023 guidelines on the diabetic foot

  2024cites this paper
• Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)

  2023cites this paper
• Diagnosis and treatment of active charcot neuro‐osteoarthropathy in persons with diabetes mellitus: A systematic review

  2023cites this paper
• The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications

  2021cites this paper
• An overview of Charcot’s neuroarthropathy

  2020cites this paper
• Pursuing mechanisms of extracellular vesicle formation. Effects of sample processing

  2020cites this paper
• Effects of Negative Pressure Wound Therapy on Levels of Angiopoetin-2 and Other Selected Circulating Signaling Molecules in Patients with Diabetic Foot Ulcer

  2019cites this paper
• What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer.

  2019cites this paper
• Neuroarthropathy in diabetes: pathogenesis of Charcot arthropathy

  2018cites this paper
• What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer

  2018cites this paper
• An investigation into the effect of Trigonella foenum-graecum L. seed extract and derivative, Vicenin-2, on inflammatory responses of macrophage and endothelial cells

  2016cites this paper